Poll Results

How have drug supply shortages in 2022 changed compared to shortages in 2021?

More products impacted: 44%

Same number of products impacted: 44%

Less products impacted: 11%

What factor will have the greatest impact on the number of unfilled pharmacist positions that currently exists?

2022 pharmacy school graduates will fill the open positions: 8.3%

Pharmacy closures will help reduce the number of unfilled positions: 58.4%

Currently employed pharmacists will see an increases in hours worked and overtime: 25.0%

Chains will reassign pharmacist administrators/HQ personnel back to the stores: 0.0%

Pharmacy schools will increase the incoming class size: 8.3%

Retired pharmacists will come out of retirement to fill hours: 0.0%

What impact will the Mark Cuban Cost Plus Drug Company Pharmacy have on drug prices in the next 2 years?

Retail pharmacies will lower their cash prices to compete: 10%

Select competing retail and internet pharmacies will lower their cash prices: 20%

Retail pharmacies will create or further enhance their own discount programs or clubs to compete: 20%

There will be an increase in discount card program utilization: 20%

No impact on pharmacy prices: 30%

What source will you rely on most to determine interchangeable biosimilar status?

FDA Purple Book: 91%

Pharmacy System and Compendia: 9%

PBM Formulary and Messaging: 0%

Pharmacist Knowledge and Education: 0%

Which stakeholder will have the most influence on the biosimilar dispensed from retail pharmacy?

PBM: 67%

Pharmacy: 17%

Biosimilar manufacturer: 8%

Physician: 8%

Patient: 0%

Wholesaler: 0%

How severe do you expect the 2021-2022 flu season to be versus previous years?

Fewer infections than 2020-2021: 0%

Similar number of infections to 2020-2021: 0%

More infections than 2020-2021 but still fewer than pre-COVID: 100%

Similar number of infections as pre-COVID: 0%

More infections than pre-COVID: 0%

Have you used telehealth services for an acute or chronic health concern?

Yes, starting pre-pandemic: 0%

Yes, starting during the pandemic: 50%

Not yet, but would consider: 50%

No, and would not consider: 0%

What impact will the new PBM from Anthem, Humana, and SS&C have on incumbents?

Significant Disruption: 0%

Minor Loss of Business: 100%

No Impact: 0%